
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp has demonstrated robust financial performance, with a notable 15% revenue increase in the Cardio & Vascular segment during the third quarter of 2025, alongside a steady 2% growth in the Cardiac Rhythm Management & Neuromodulation segment. The company's gross margins are anticipated to remain stable, projected at 27.3% for 2025 and 27.0% for 2026, indicative of effective cost management strategies amid expected revenue growth to $1.87 billion for 2026. Additionally, Integer is expected to maintain strong operating cash flow, increasing from $205 million in 2024 to a range of $230-$240 million in 2025, which will contribute to improved leverage ratios and position the company favorably for ongoing market opportunities driven by new product launches and favorable industry trends.
Bears say
Integer Holdings Corp has adjusted its revenue estimates for 4Q25E to $460.0 million, reflecting a 2% increase year-over-year but a decline from previous forecasts, accompanied by lowered adjusted EPS expectations to $1.66. The company has also revised its full-year 2025 revenue guidance downward by $16 million, citing reduced demand for key products, and has adopted a flat-to-lower outlook for 2026E, anticipating ongoing sales headwinds from slower market adoption. Furthermore, the expected sales growth is now significantly lower than historical norms, with projections indicating a decline in adjusted operating income of approximately 1.5%, primarily due to disappointing performance from three specific product lines.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares